Omron Corp. (OTCMKTS:OMRNY – Get Free Report) shares rose 6.3% on Friday . The stock traded as high as $33.42 and last traded at $33.37. Approximately 1,158 shares changed hands during trading, a decline of 98% from the average daily volume of 55,031 shares. The stock had previously closed at $31.39.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on OMRNY shares. Zacks Research cut Omron from a “hold” rating to a “strong sell” rating in a report on Thursday, June 11th. Jefferies Financial Group downgraded Omron from a “buy” rating to a “hold” rating in a report on Tuesday, June 16th. One investment analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce”.
View Our Latest Stock Analysis on OMRNY
Omron Trading Up 1.8%
Omron Company Profile
Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.
Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.
Recommended Stories
- Five stocks we like better than Omron
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.
